A Two-Week, Randomised, Double-Blind Study Assessing the Onset of Effect Questionnaire Administered Daily Versus Weekly in Adult Subjects (greater than or equal to 18 Years) With Mild to Moderate Asthma, Receiving SYMBICORT pMDI 80/4.5 μg x 2 Actuations Twice Daily or Budesonide HFA pMDI 80 μg x 2 Actuations Twice Daily
Phase of Trial: Phase III
Latest Information Update: 01 Dec 2009
At a glance
- Drugs Budesonide; Budesonide/formoterol
- Indications Asthma
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 11 Jan 2008 Status changed from in progress to completed.
- 12 Oct 2007 Status changed from recuiting to in progress.
- 28 May 2007 New trial record.